Metabolon Enters Into Agreement With The Carlos Slim Institute, Patia and Clinica Ruiz For Quantose Prediabetes Test In Mexico
2/25/2014 9:35:41 AM
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Metabolon, Inc., the world leading metabolomics company announced today the signing of several exclusive multi-year, royalty-based Research Collaboration and Licensing agreements with Patia Biopharma, a Mexican biotech company working to make personalized preventive medicine a reality in Mexico and Latin America. The Research Collaboration provides Metabolon’s Quantose IR™ technology for use in several Diabetes Prevention Studies in Mexico. The License agreement provides exclusive access in Mexico to Metabolon’s prediabetes test technology for assessing insulin resistance in the general population of Mexico through Patia and Clinica Ruiz’s network of laboratories.
Help employers find you! Check out all the jobs and post your resume.
comments powered by